Analyst Ratings for Roivant Sciences (ROIV)
ROIV Rating Summary
ROIV Price Target Summary
- Highest: $38.00 (TD Cowen)
- Lowest: $16.50 (BofA Securities)
- Average: $30.95
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$30.95 (+7.5%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$30.95 (+7.5%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/2/2025 | Citi » Updated 2/10/2026 |
Samantha Semenkow | New Coverage | Buy (N/A) |
35.00 (26.00) |
11.93 (28.78) |
141.24% | Details |
| 7/10/2025 | Goldman Sachs » Updated 2/10/2026 |
Corinne Jenkins | New Coverage | Buy (N/A) |
38.00 (36.00) |
11.22 (28.78) |
156.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
